pcos and glp-1 medications are getting attention in care — but they aren't right for everyone. PCOS isn't one condition. For some patients, symptoms are driven by insulin resistance. GLP-1s work by improving Beneficial effects of GLP-1 receptor

OConnor, 2025)

36 GLP-1 Agonists in Obesity Management Since the 1970s, global rates of overweight and obesity, determined by a body mass index (BMI) of 25.029.9 kg/m2 and 30.0 kg/m2, respectively, have almost tripled

About this article Cite this article Arvanitakis, K., Koufakis, T., Popovic, D

Because tirzepatide can be powerful even at lower doses for some patients, careful provider oversight is still important

In a clinical trial, one-year dulaglutide treatment in individuals with chronic kidney disease (CKD) and T2D resulted in an increased estimated glomerular filtration rate compared to insulin glargine

In one study published in Molecular Nutrition and Food Research, nicotinamide supplementation protected mice against diet-induced obesity, increased energy expenditure, and induced the beiging of white adipose tissue, a process that converts energy-storing fat cells into energy-burning cells